Beta-thalassemia (B-thal) Market

The iron-chelating agents appear to be in charge of the Beta-Thalassemia market outlook. Exjade is the first commercially available once-daily oral iron chelator for the treatment of chronic transfusional iron excess caused by a variety of underlying anem...